Koo Jakap 4
4 · Apimeds Pharmaceuticals US, Inc. · Filed May 14, 2025
Insider Transaction Report
Form 4
Koo Jakap
Director
Transactions
- Purchase
Common Stock, par value $0.01 per share
2025-05-12$1.99/sh+28,500$56,715→ 643,885 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Apimeds Pharmaceuticals US, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F2]These shares were sold in multiple transactions at prices ranging from $1.9774 to $2.2000, inclusive.